| Financial Year |
March 31 2023 |
| Monetary Funds |
1,411,166,987.52 |
| Held-for-trading Financial Assets |
2,426,088.63 |
| Notes Receivable |
26,214,242.22 |
| Accounts Receivable |
2,354,005,250.29 |
| Advances to Suppliers |
362,578,456.00 |
| Other Receivables |
107,067,046.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,730,741,259.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
39,159,562.82 |
| Total Current Assets |
6,774,987,136.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,041,951,911.47 |
| Investment Properties |
77,300,706.99 |
| Fixed Assetes |
554,415,451.66 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
151,875,035.74 |
| R&D expenses |
92,983,107.03 |
| Goodwill |
1,507,659.11 |
| Long-Term Deferred and Prepaid Expenses |
28,533,003.31 |
| Deferred Income Tax Assets |
89,849,568.02 |
| Other Non-Current Assets |
13,777,236.00 |
| Sub-Total of Non-Current Assets |
2,842,824,429.31 |
| Total Assets |
9,617,811,566.20 |
| Short-Term Loans |
681,305,534.71 |
| Trading Financial liabilities |
-- |
| Notes Payable |
206,329,931.03 |
| Accounts Payable |
2,916,216,428.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
85,397,191.77 |
| Taxes Payable |
77,955,226.66 |
| Interest Payable |
4,812,590.00 |
| Dividend Payable |
14,637,970.30 |
| Other payables |
606,864,695.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
137,244,795.84 |
| Other Current Liabilities |
20,549,435.49 |
| Sub-Total of Current Liabilities |
5,399,811,999.86 |
| Long-term Loans |
610,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
27,600,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
29,495,453.45 |
| Deferred Income Tax Liabilities |
15,843,017.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
840,817,861.27 |
| Total Liabilities |
6,240,629,861.13 |
| Paid-In Capital(Or Share Stock) |
661,696,417.00 |
| Capital Surplus |
1,373,427,908.01 |
| Surplus Reserve |
70,662,931.69 |
| LESS:Treasury Stock |
394,916,931.00 |
| Undistributed Profits |
629,743,605.16 |
| Minority Stockholder's Interest |
1,065,074,796.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,312,106,908.42 |
| Owner's Equity（Stockholder's Equity） |
3,377,181,705.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,617,811,566.20 |
